
No data
No data
No data
| CAS Number | 84057-84-1 |
| Catalog Number | AG0036DQ(AGN-PC-04XSOH) |
| Chemical Name | 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine |
| EC Number | 281-901-8 |
| IUPAC Name | 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine |
| InChI | InChI=1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16) |
| InChI Key | PYZRQGJRPPTADH-UHFFFAOYSA-N |
| MDL Number | MFCD00865333 |
| Molecular Formula | C9H7Cl2N5 |
| Molecular Weight | 256.0914 |
| SMILES | ClC1=C(C=CC=C1Cl)C1=C(N=C(N=N1)N)N |
| UNII | U3H27498KS |
| Synonyms | 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine,
3,5-diamino-6-(2,3-dichlorophenyl)-as-triazine,
BW 430C,
BW-430C,
BW430C,
Crisomet,
Labileno,
Lamictal,
Lamiktal,
lamotrigine,
lamotrigine,
84057-84-1,
6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine,
Lamictal,
Lamictal Cd,
Lamotrigina,
Lamotriginum,
Lamictal XR,
Lamotriginum [Latin],
Lamotrigina [Spanish],
BW-430C,
Lamictal ODT,
BW 430C,
3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine,
1,2,4-Triazine-3,5-diamine, 6-(2,3-dichlorophenyl)-,
3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazine,
UNII-U3H27498KS,
EINECS 281-901-8,
MFCD00865333,
CHEMBL741,
C9H7Cl2N5,
GW 273293,
MLS000069685,
CHEBI:6367,
PYZRQGJRPPTADH-UHFFFAOYSA-N,
U3H27498KS,
Lamotrigine, 98%,
NCGC00015605-06,
Labileno,
Lamiktal,
Lamitor,
SMR000058464,
DSSTox_CID_3195,
DSSTox_RID_76918,
DSSTox_GSID_23195,
Lamictin,
Lamictal (TN),
CAS-84057-84-1,
Lamotrigine [USAN:INN:BAN],
BW430C,
SR-01000000187,
Lamotrigine (JAN/USAN/INN),
HSDB 7526,
EUR-1048,
Lamotrigine [USAN:USP:INN:BAN],
zine-3,5-diamine,
GI 267119X,
Opera_ID_12,
Tocris-1611,
hydroxymethyl progesterone,
AC1L1GWT,
Lopac-L-3791,
L 3791,
Lopac0_000688,
SCHEMBL35439,
MLS000759486,
MLS001077325,
MLS001423991,
BIDD:GT0794,
Lamotrigine, >=98%, powder,
GTPL2622,
TRI020,
DTXSID2023195,
CTK8B4406,
KS-00000XIV,
ZINC13156,
HMS2051C10,
HMS2089M08,
HMS2093P21,
HMS2230L04,
HMS3262I17,
HMS3268G17,
HMS3371O16,
HMS3393C10,
HMS3657A17,
HMS3715H21,
Pharmakon1600-01505610,
BCP12156,
HY-B0495,
Lamotrigine 1.0 mg/ml in Methanol,
Tox21_110179,
Tox21_500688,
ANW-44921,
BDBM50031299,
NSC746307,
NSC759171,
s3024,
STK628377,
AKOS005561147,
Tox21_110179_1,
6-(2,2,4-triazine-3,5-diyldiamine,
CCG-100856,
CS-2616,
DB00555,
KS-1074,
LP00688,
MCULE-7648410888,
NC00106,
NE61394,
NSC-746307,
NSC-759171,
SMP2_000303,
NCGC00015605-01,
NCGC00015605-02,
NCGC00015605-03,
NCGC00015605-04,
NCGC00015605-05,
NCGC00015605-07,
NCGC00015605-08,
NCGC00015605-09,
NCGC00015605-10,
NCGC00022936-02,
NCGC00022936-04,
NCGC00022936-05,
NCGC00261373-01,
AC-10298,
AJ-08354,
AK-72807,
AN-35947,
AT-15488,
BC200572,
BR-72807,
CPD000058464,
K499,
SAM001246697,
SC-12025,
SBI-0050666.P002,
6-(2,3-Dichloro-phenyl)-[1,2,4]tria,
AB0014255,
LS-155249,
TR-026049,
B2249,
EU-0100688,
FT-0602546,
L-205,
L0241,
ST24024203,
SW197486-3,
57L841,
A11873,
D00354,
J10032,
AB00384359-16,
AB00384359_17,
AB00384359_18,
A840709,
3,5-diamino-(2,3-dichlorophenyl)-1,2,4-triazine,
3,5-diamino-6-(2,3-dichlorophenyl)- as -triazine,
Q-201221,
SR-01000000187-2,
SR-01000000187-4,
SR-01000000187-7,
BRD-K93460210-071-01-6,
SR-01000000187-10,
3,5-diamino-6-(2,3,-dichlorophenyl)-1,2,4-triazine,
6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine.,
F2173-0540,
Z1550648755,
6-(2,3-Dichloro-phenyl)-[1,2,4]triazine-3,5-diamine,
6-[2,3-bis(chloranyl)phenyl]-1,2,4-triazine-3,5-diamine,
Lamotrigine, British Pharmacopoeia (BP) Reference Standard,
Lamotrigine, European Pharmacopoeia (EP) Reference Standard,
6-(2,3-Dichloro-phenyl)-[1,2,4]triazine-3,5-diamine(lamotrigine),
GI 267119X; 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine,
Lamotrigine, United States Pharmacopeia (USP) Reference Standard,
Lamotrigine, Pharmaceutical Secondary Standard; Certified Reference Material,
Lamotrigine for peak identification, European Pharmacopoeia (EP) Reference Standard,
Lamotrigine for system suitability, European Pharmacopoeia (EP) Reference Standard,
Lamotrigine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material,
Crisomet,
lamitrin,
lamotrigin,
Lamictin (TN),
Faes Brand of Lamotrigine,
D03FLC,
Juste Brand of Lamotrigine,
Desitin Brand of Lamotrigine,
Lamotrigine [USAN:BAN:INN],
C9-H7-Cl2-N5,
CID3878,
Glaxo Wellcome Brand of Lamotrigine,
GlaxoSmithKline Brand of Lamotrigine,
CS-O-11675,
C047781,
D000077213,
6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diyldiamine,
Lamotrigine, 98%, a novel anticonvulsant drug for inhibition of 5-HT - 1G 1g,
LTg,
|
| Complexity | 242 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 255.008g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 16 |
| Hydrogen Bond Acceptor Count | 5 |
| Hydrogen Bond Donor Count | 2 |
| Isotope Atom Count | 0 |
| Molecular Weight | 256.09g/mol |
| Monoisotopic Mass | 255.008g/mol |
| Rotatable Bond Count | 1 |
| Topological Polar Surface Area | 90.7A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 1.4 |
| Symbol: | |
| Hazard Class | 6.1 |
| Hazard statements | H301 |
| Packing Group | Ⅲ |
| Precautionary statements | P301+P310 |
| UN Code | UN 2811 |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

